MORGAN STANLEY - Dec 31, 2024 SCHEDULE 13G Report for C4 Therapeutics, Inc. Common Stock (CCCC)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: C4 Therapeutics, Inc. Common Stock
Symbol: CCCC
Shares outstanding: 70.9M shares
Disclosed Ownership: 3.83M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Date filed: 2/3/2025, 01:59 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	5.4%	3.83M	0	3.83M	Christopher O'Hara	Authorized Signatory, Morgan Stanley

Showing 1 to 1 of 1 entries